T0	MultiCitation 3395 3416	Narendra et al., 2010
T1	MultiCitation 5696 5717	Narendra et al., 2010
T2	MultiCitation 6581 6602	Narendra et al., 2010
T3	MultiCitation 8252 8273	Narendra et al., 2010
T4	MultiCitation 28453 28474	Narendra et al., 2010
T5	MultiCitation 32767 32788	Narendra et al., 2010
T6	Span 3160 3525	Recent cell-based and in vivo studies have revealed that PINK1 acts upstream of another gene product that is relevant to Parkinson's disease, Parkin (Clark et al., 2006; Geisler et al., 2010; Kitada et al., 1998; Matsuda et al., 2010; Narendra et al., 2010; Park et al., 2006; Rakovic et al., 2010; Vives-Bauza et al., 2010; Yang et al., 2006; Ziviani et al., 2010)
R1	Context Target:T0 Context:T6	
T7	Span 5438 5741	PINK1 thus bypasses ΔΨm-dependent degradation, which triggers the accumulation of PINK1 on the OMM, interaction with the translocase of the outer membrane (TOM) complex, PINK1 dimerization and autophosphorylation (Lazarou et al., 2012; Matsuda et al., 2010; Narendra et al., 2010; Okatsu et al., 2012b).
R2	Context Target:T1 Context:T7	
T8	Span 8061 8296	Although PINK1 has been shown to localize on the OMM of depolarized mitochondria and undergo autophosphorylation-dependent activation in response to a decrease in ΔΨm, (Matsuda et al., 2010; Narendra et al., 2010; Okatsu et al., 2012b)
R3	Context Target:T3 Context:T8	
T9	Span 28257 28475	However, overexpression of exogenous PINK1 itself (even the wild-type form) triggers mitochondrial localization and autoubiquitylation of Parkin even in the absence of CCCP (Matsuda et al., 2010; Narendra et al., 2010)
R4	Context Target:T4 Context:T9	
T10	Span 32599 32812	When ΔΨm is reduced, the driving force for matrix import decreases, resulting in the accumulation of activated PINK1 on depolarized mitochondria (Matsuda et al., 2010; Narendra et al., 2010; Okatsu et al., 2012b).
R5	Context Target:T5 Context:T10	
